Where it may be relevant
- Travellers visiting a malaria-risk area where atovaquone/proguanil is recommended
- Shorter trips where the seven-day post-travel course may be preferable
- Adults and children meeting the product's age and weight requirements
Dose schedules.
The clinician will select the appropriate licensed schedule after reviewing age, health, previous doses and departure date.
Daily prevention
Adults and weight-eligible children
Take at the same time each day with food or a milky drink.
Who may be eligible
- People whose itinerary, medical history and medicines support this option
- Children prescribed the correct tablet strength and dose for their weight
Who may not be eligible
- People with severe renal impairment for malaria prevention
- Anyone allergic to atovaquone, proguanil or an ingredient
- Pregnancy, breastfeeding a low-weight infant, vomiting, diarrhoea and interacting medicines require individual review
Potential side effects
- Nausea, stomach pain, diarrhoea or headache
- Mouth ulcers, cough or dizziness can occur
- Taking each dose with food or a milky drink improves absorption
Important risks and precautions
- No antimalarial guarantees complete protection; bite avoidance remains essential
- Vomiting soon after a dose may require another dose and clinical advice
- Fever during travel or within a year of return requires urgent medical assessment and a clear travel history
Clinical references
Further information.
- TravelHealthPro malaria guidance
- UK malaria prevention guidelines
- Atovaquone/proguanil product information
Information is general and does not replace a personal assessment, prescribing decision or the latest destination-specific advice.
